The Net Margin of Mayinglong Pharmaceutical Group Co Ltd (600993.SS) is 15.03%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | 15.03% |
| 2024-12-31 | 14.16% |
| 2023-12-31 | 14.13% |
| 2022-12-31 | 13.56% |
| 2021-12-31 | 13.72% |
| 2020-12-31 | 15.01% |
| 2019-12-31 | 13.31% |
| 2018-12-31 | 8.02% |
| 2017-12-31 | 18.29% |
| 2016-12-31 | 11.90% |